AbbVie
ABBV
#26
Rank
C$517.02 B
Marketcap
$292.27
Share price
-0.52%
Change (1 day)
19.25%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): C$4.87 Billion

According to AbbVie's latest financial reports the company's current earnings are C$56.33 Billion. a decrease over its 2023 earnings that were of C$8.90 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 C$5.29 B-40.54%
2023 C$8.90 B-53.62%
2022 C$19.19 B3.76%
2021 C$18.50 B282.25%
2020 C$4.84 B-59.67%
2019 C$12.00 B62.13%
2018 C$7.40 B-32.74%
2017 C$11.00 B-1.99%
2016 C$11.22 B18.65%
2015 C$9.46 B180.5%
2014 C$3.37 B-55.57%
2013 C$7.59 B-6.86%
2012 C$8.15 B56.05%
2011 C$5.22 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$15.82 B 199.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.94 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.06 B 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.56 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.98 B-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.71 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.25 B 18.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$14.86 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.73 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA